Dr Matthew R. Crittall

Senior Scientist / Medicinal Chemist / Web Designer / Software Developer

Education

University of Bath, Bath, UK

PhD in Synthetic Organic Chemistry, 2008 - 2012

Thesis title: An Investigation into Helical Asymmetry – Design, Synthesis and Evaluation of a Helicenoidal DMAP Analogue Nucleophilic Catalyst.

University of Bath, Bath, UK

MChem (hons) Chemistry with Industrial Training (First Class), 2004 - 2008

Overall grade average: 77%

The Windsor Boys’ School, Windsor, Berkshire, UK

A-Levels, 1999 - 2004

A-Levels: Chemistry (A), Biology (A), Geography (A)
GCSEs: 9 GCSE passes at A* (5) and A (4) including Chemistry, Maths and English


Publications

Abnormal coordination of Arduengo's carbene upon reaction with M3(CO)12 (M = Ru, Os) Crittall, M. R; Ellul, C. E; Mahon, M. F; Saker, O; Whittlesey, M. K. Dalton Transactions, 2008, 32, 4209.

Design, Synthesis and Evaluation of a Helicenoidal DMAP Lewis Base Catalyst Crittall, M. R; Rzepa, H. S.; Carbery, D. R. Org. Lett. 2011, 13, 1250.

Point-to-helical transfer for a scalable and resolution-free synthesis of a helicenoidal DMAP organocatalyst Crittall, M. R; Fairhurst, N. W. G; Carbery, D. R. Chem. Commun., 2012, 48, 11181.

In vitro and in vivo antifungal profile of a novel and long acting inhaled azole, PC945, on Aspergillus fumigatus infection Kazuhiro Ito, Thomas Colley, Pete Strong, Garth Rapeport, Gurpreet Sehra, Lauren Anderson-Dring, John Murray, Alexandre Alanio, Steven Kelly, Diane Kelly, Andrew Warrilow, Josie Parker, Yasuo Kizawa, Genki Kimura, Takahiro Nakaoki, Mihiro Sunose, Stuart Onions, Damien Crepin, Franz Legasse, Matthew Crittall, Jonathan Shannon, Michael Crooke, John King-Underwood, and Stephane Bretagne. Submitted for publication to Antimicrobial Agents and Chemotherapy (2017)


Experience

Sygnature Discovery, Biocity, Nottingham, UK, Jan 2014 -

Senior Scientist - Medicinal Chemistry

I am responsible for providing integrated drug discovery services to a variety of clients. I have worked in a multitude of therapeutic areas – anti-fungal, anti-cancer, type II diabetes, anti-inflammatory. This has involved playing a key role in both the design and synthesis of novel medicines and the understanding of complex pharmacokinetic and pharmacological data to drive projects. In addition, I have contributed to the development and scale-up of novel anti-fungal medicines, one of which has now entered early-stage clinical trials. I have also been involved in numerous multi-gram scale-ups to support PK and animal studies for novel type II diabetes drug candidates – one of which has been nominated for phase I clinical trials

Peakdale Chemistry Services, Discovery Park, Sandwich, Kent, UK, May 2012 - Dec 2013

Synthetic Organic Chemist - Medicinal Chemistry

My time at Peakdale entalied taking responsibility for synthesising and delivering requested pharmaceutical targets to the customer (Pfizer). I was also a supervisor of a Microsoft Visual Basic operated high-throughput automated purification system and analytical chiral HPLC system.

Department of Investigative Pre-Clinical Toxicology, GlaxoSmithKline, Ware, Hertfordshire, UK, 2006 - 2007

Industrial Placement Student

My time as a placement student at GSK involved developing a generic extraction method to improve analysis of the metabolome of control animal tissues. Large quantities of complex multivariate data were interpreted using Principal Component Analysis (PCA).


Skills Profile

Technical

General

Communication

Leadership


Achievements


Interests

Connect

Copyright 2017 Matthew R. Crittall